Trademark: 97106924
Word
PURMINDS
Status
Pending
Status Code
645
Status Date
Tuesday, December 5, 2023
Serial Number
97106924
Mark Type
4000
Filing Date
Wednesday, November 3, 2021

Trademark Owner History

Classifications
9 Downloadable computer software programs for database management in the biotechnology field, namely, software for creating and visualizing in-silico models of biological systems, in particular 3D models of human and brain cells, and to generate new data to detail, predict and modulate complex molecular mechanisms and interactions with the systems and network levels; Downloadable software programs using artificial intelligence and machine learning for data analysis, data screening, and data processing in the fields of computational biology, In Silico experiments, robotic Microscopy, molecular assembler, brain-computer interface, bioinformatics, and neuroinformatics, to develop predictive models to accelerate drug discovery; Downloadable software applications using artificial intelligence and machine learning for data analysis for scientific and pharmaceutical product development and research purposes; downloadable software application for use in collecting and analyzing data related to neurological disorders, neurodegenerative diseases, Alzheimer's disease, and bioinformatics
5 Nutritional and natural dietary supplements, to support mental performance and brain health, namely supplements for neuroprotection, supplements that contain nootropics; Prescription pharmaceutical preparations for the prevention and treatment of neurological disorders and neurodegenerative diseases and Alzheimer's disease; Pharmaceuticals, namely, psychotropics, psychoactive compounds, and non-psychoactive compounds and molecules for the prevention and treatment of neurological disorders, neurodegenerative diseases, and Alzheimer's disease
35 Advertising and marketing of nutritional and dietary supplements and psychoactive compounds derived from natural sources and chemical synthesis of others; Wholesale distributorships, on-line wholesale and retail store services featuring nutritional and dietary supplements and psychoactive compounds derived from natural sources and chemical synthesis; analysis of neuroinformatic data and algorithms generated through the drug discovery process for business purposes
45 Analyzing statistical neuroinformatic health data generated through the drug discovery process in order to uncover and identify health care fraud and claims errors
44 Providing medical information, consultancy and advisory services related to the treatment of neurological disorders, neurodegenerative diseases, and Alzheimer's disease; Providing information about health and wellness, namely, in the field of psychotropics, psychoactive compounds and non-psychoactive compounds and molecules; Clinical therapeutic drug monitoring, in the nature of drug use screening services for medical purposes; Medical screening and analytical services in the neuroscience field relating to the treatment of persons; remote monitoring of neuroinformatic medical data and algorithms generated through the drug discovery process for medical diagnosis and treatment
42 Research and development of prescriptions pharmaceutical preparations for the prevention and treatment of neurological disorders and neurodegenerative diseases, and Alzheimer's disease; Research and development of a portfolio of psychotropics, psychoactive compounds and non-psychoactive compounds and molecules for the prevention and treatment of neurological disorders and neurodegenerative diseases, and Alzheimer's disease; Laboratory analysis in the field of psychoactive drugs; Clinical laboratory testing and toxicology service, namely, molecular and endocrinology chemical analysis; medical laboratory services; laboratory testing in the nature of laboratory analysis of biologic substances for metals, occupational, and environmental toxins; Providing on-line non-downloadable software for machine learning in the fields of generating in-silico simulations of physiological responses for scientific, pharmaceutical research, product development, and educational purposes; Engineering and technical assistance in the nature of computer software consultation in the field of computer software that provides dynamic simulations of physiology for scientific, pharmaceutical research, product development, and educational purposes; Software design, engineering, and development services in the fields of artificial intelligence, machine learning, computational biology, In Silico analyses and screening, robotic Microscopy, molecular assembler, brain-computer interface, bioinformatics, neuroinformatic and consultation services related thereto
PURE MINDS

Trademark Events
Feb 22, 2024
Application Extension Granted/Receipt Provided
Feb 22, 2024
Application Extension To Response Period - Received
Dec 5, 2023
Notification Of Final Refusal Emailed
Dec 5, 2023
Final Refusal E-Mailed
Dec 5, 2023
Final Refusal Written
Nov 7, 2023
Assigned To Examiner
Oct 27, 2023
Teas/Email Correspondence Entered
Oct 26, 2023
Correspondence Received In Law Office
Oct 26, 2023
Teas Response To Office Action Received
Oct 26, 2023
Teas Change Of Correspondence Received
Oct 26, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 26, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 25, 2023
Application Extension Granted/Receipt Provided
Jul 25, 2023
Application Extension To Response Period - Received
Apr 26, 2023
Notification Of Non-Final Action E-Mailed
Apr 26, 2023
Non-Final Action E-Mailed
Apr 26, 2023
Non-Final Action Written
Apr 10, 2023
Assigned To Examiner
Nov 13, 2021
New Application Office Supplied Data Entered
Nov 6, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24